Deutsche Bank Ag\ Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $6.6 Million - $6.94 Million	-45,560 Reduced 46.05%	53,372 $8.07 Million
Q2 2022 Aug 11, 2022	SELL	$83.14 - $145.99 $55.9 Million - $98.1 Million	-671,935 Reduced 87.17%	98,932 $14.4 Million
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $2.98 Million - $3.87 Million	-27,113 Reduced 3.4%	770,867 $91.4 Million
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $5.98 Million - $8.91 Million	60,009 Added 8.13%	797,980 $110 Million
Q3 2021 Nov 04, 2021	SELL	$98.85 - $138.91 $1.61 Million - $2.27 Million	-16,323 Reduced 2.16%	737,971 $103 Million
Q2 2021 Aug 11, 2021	BUY	$65.78 - $105.02 $1.82 Million - $2.9 Million	27,614 Added 3.8%	754,294 $73.2 Million
Q1 2021 May 13, 2021	BUY	$64.07 - $91.75 $39.1 Million - $55.9 Million	609,527 Added 520.28%	726,680 $49.7 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $26.7 Million - $40.3 Million	-410,537 Reduced 77.8%	117,153 $10 Million
Q3 2020 Nov 12, 2020	SELL	$59.04 - $77.95 $4.9 Million - $6.47 Million	-82,957 Reduced 13.59%	527,690 $34.3 Million
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $1.29 Million - $3.29 Million	44,314 Added 7.82%	610,647 $44.6 Million
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $2.02 Million - $4.22 Million	73,576 Added 14.93%	566,333 $19.3 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $16.3 Million - $23.1 Million	399,876 Added 430.53%	492,757 $26.8 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $2 Million - $2.65 Million	-53,470 Reduced 36.54%	92,881 $3.87 Million
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $5.86 Million - $9.87 Million	-147,244 Reduced 50.15%	146,351 $6.41 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $3.76 Million - $5.8 Million	108,829 Added 58.9%	293,595 $15.1 Million
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $2.39 Million - $3.44 Million	-80,244 Reduced 30.28%	184,766 $6.83 Million
Q3 2018 Dec 21, 2021	BUY	$32.79 - $43.0 $1.87 Million - $2.45 Million	57,003 Added 27.4%	265,010 $9.95 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $253,204 - $332,046	7,722 Added 3.86%	208,007 $7.81 Million
Q2 2018 Apr 21, 2020	BUY	$23.62 - $42.29 $255,662 - $457,746	10,824 Added 5.71%	200,285 $7.92 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $3.02 Million - $5.4 Million	127,683 Added 206.68%	189,461 $7.49 Million
Q1 2018 Oct 18, 2019	BUY	$22.49 - $34.56 $198,969 - $305,752	8,847 Added 16.71%	61,778 $1.59 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $660,103 - $1.01 Million	29,351 Added 124.47%	52,931 $1.36 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $107,269 - $186,618	5,248 Added 28.63%	23,580 $635,000
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $431,535 - $700,465	18,332	18,332 $683,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account